Case report: agranulocytosis induced by interferon-alpha therapy for chronic hepatitis C.

No abstract is available for this paper.

• Publication year

  1996

• Venue

  Journal of Gastroenterology and Hepatology

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  PMID 8985818
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Granulocytopenia after combined therapy with interferon and angiotensin-converting enzyme inhibitors: evidence for a synergistic hematologic toxicity.

  1995cited by this paper
• [Clinical applications of cytokines in pediatrics].

  1994cited by this paper
• Phase II evaluation of fluorouracil and recombinant α‐2a‐interferon in previously untreated patients with pancreatic adenocarcinoma

  1992cited by this paper
• Treatment of drug-induced agranulocytosis with granulocyte-colony stimulating factor.

  1989cited by this paper
• Recombinant human granulocyte colony-stimulating factor: effects on normal and leukemic myeloid cells.

  1986cited by this paper
• Clinical toxicity of interferons in cancer patients: a review.

  1986cited by this paper
• Changes in the bone marrow of cancer patients treated with recombinant interferon alpha-2.

  1984cited by this paper

• Human Parvoviruses

  2016cites this paper
• Pegylated-interferon-α2a in clinical practice: how to manage patients suffering from side effects

  2011cites this paper
• Severe Agranulocytosis as a Rare Side Effect of Pegylated Interferon Therapy for Chronic Hepatitis B

  2011cites this paper
• [Complementary treatments of chronic viral hepatitis C].

  2006cites this paper
• Traitements complmentaires de lhpatite chronique virale C

  2006cites this paper
• Defective Synthesis of Granulocyte-Colony Stimulating Factor in Pegylated Interferon-α Treated Chronic Hepatitis C Patients with Declining Leukocyte Counts

  2005cites this paper
• Side Effects of Therapy of Hepatitis C and Their Management

  2005cites this paper
• Role of epoetin alfa in maintaining ribavirin dose.

  2004cites this paper
• [Monitoring of iatrogenic neutropenia: importance of the pharmacovigilance analysis].

  2004cites this paper
• Side effects of therapy for chronic hepatitis C.

  2003cites this paper
• Side effects of therapy of hepatitis C and their management

  2002cites this paper
• [Interferon alpha-associated agranulocytosis during clozapine treatment. Case report and status of current knowledge].

  2001cites this paper
• Acute pancreatitis attributed to the use of interferon alfa-2b.

  2000cites this paper
• Interferon-alpha-induced agranulocytosis in a patient on long-term clozapine therapy.

  1998cites this paper